TR
3SBio Inc.
TRSBF · OTC
$2.15 +0.00% (+$0.00)
Market Cap ¥36.0B
P/E Ratio 4.36x
Div. Yield 1.48%
ROE 38.21%
Bulios Fair Price
$2.87
33.5% upside
Current Price
$2.15
Undervalued Fair Value Overvalued
According to Bulios Fair Price, TRSBF is currently undervalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Piotroski F-Score Strong
7/9Valuation
97 /100
Cheap P/B 1.32x
P/S 2.09x
P/E 4.36x
Growth
100 /100
Growing Book val. growth 28.06%
FCF growth 96.31%
EPS growth 65.59%
Profitability
100 /100
Strong FCF margin 52.95%
Op. margin 59.66%
Gross margin 92.38%
Quality
91 /100
Excellent Asset turnover 0.48x
ROA 22.78%
ROIC 25.83%
Debt
100 /100
Low Net debt/EBITDA -0.90x
Int. coverage 138.22x
Debt/Equity 0.10x
Stability
31 /100
Unstable Profitable years 6
EPS volatility 166.61%
Beta 0.45x
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about TRSBF
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Jing Lou
Employees
6,109
Headquarters
Shenyang
Upcoming events
30 MAR
Earnings
Upcoming earnings report